(Press-News.org) ANN ARBOR—A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood—and it can support the cells' growth for further analysis.
The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide. In clinics, such a device could one day help doctors diagnose cancers, give more accurate prognoses and test treatment options on cultured cells without subjecting patients to traditional biopsies.
"If we can get these technologies to work, it will advance new cancer drugs and revolutionize the treatment of cancer patients," said Dr. Max Wicha, director of the U-M Cancer Center and co-author of a paper on the new device, published online this week in Nature Nanotechnology.
"Circulating tumor cells will play a significant role in the early diagnosis of cancer and to help us understand if treatments are working in our cancer patients by serving as a 'liquid' biopsy to assess treatment responses in real time," said co-author Dr. Diane Simeone, the Lazar J. Greenfield Professor of Surgery at the U-M Medical School and director of the Translational Oncology Program.
"Studies of circulating tumor cells will also help us understand the basic biologic mechanisms by which cancer cells metastasize or spread to distant organs—the major cause of death in cancer patients."
Yet these cells aren't living up to their promise in medicine because they are so difficult to separate from a blood sample, the researchers say. In the blood of early-stage cancer patients, they account for less than one in every billion cells, so catching them is tougher than finding the proverbial needle in a haystack.
"I can burn the haystack or use a huge magnet," said Sunitha Nagrath, an assistant professor of chemical engineering, who led the research. "When it comes to circulating tumor cells, they almost look like—feel like—any other blood cell."
On their microfluidic chip, Nagrath's team grew dense forests of molecular chains, each equipped with an antibody to grab onto cancer cells.
Even after the cells are caught, it's still hard to run a robust analysis on just a handful of them, the researchers say. That's why this demonstration of highly sensitive tumor cell capture, combined with the ability to grow the cells in the same device, is so promising.
Hyeun Joong Yoon, a postdoctoral researcher in the Nagrath lab with a background in electrical engineering, was instrumental in making the microfluidic chip. He started with a silicon base and added a grid of nearly 60,000 flat gold shapes, like four-petaled flowers, each no wider than a strand of hair.
The gold flowers naturally attracted a relatively new material called graphene oxide. These sheets of carbon and oxygen, just a few atoms thick, layered themselves over the gold. This layered formation allowed the team to grow the tumor-cell-catching molecular chains so densely.
"It's almost like each graphene has many nano-arms to capture cells," Nagrath said.
To test the device, the team ran one-milliliter samples of blood through the chip's thin chamber. Even when they had added just three-to-five cancer cells to the 5-10 billion blood cells, the chip was able to capture all of the cells in the sample half the time, with an average of 73 percent over 10 trials.
"That's the highest anybody has shown in the literature for spiking such a low number of cells," Nagrath said.
The team counted the captured cancer cells by tagging them with fluorescent molecules and viewing them through a microscope. These tags made the cancer cells easy to distinguish from accidentally caught blood cells. They also grew breast cancer cells over six days, using an electron microscope to see how they spread across the gold flowers.
"When you have individual cells, the amount of material in each cell is often so small that it's hard to develop molecular assays," Wicha said. "This device allows the cells to be grown into larger quantities so you can do a genetic analysis more easily."
The chip could capture pancreatic, breast and lung cancer cells from patient samples. Nagrath was surprised that the device was able to catch about four tumor cells per milliliter of blood from the lung cancer patients, even though they had the early-stage form of the disease.
Working in a team that comprises both engineers and medical professionals at U-M, Nagrath is optimistic that the new technique could reach clinics in three years.
The paper is titled "Sensitive capture of circulating tumor cells by functionalized graphene oxide nanosheets." The university is pursuing patent protection for the intellectual property and is seeking commercialization partners to help bring the technology to market.
INFORMATION:
Sunitha Nagrath: http://www.engin.umich.edu/dept/che/research/nagrath
Translational Oncology Program:
http://www.cancer.med.umich.edu/news/translational-oncology-program2012.shtml
END
BOSTON (Sept. 30, 2013) — Short-term hearing loss during childhood may lead to persistent hearing deficits, long after basic auditory sensitivity has returned to normal. The processing of sound in the brain is shaped by early experience. New research from Massachusetts Eye and Ear has identified two critical periods occurring shortly after hearing onset that regulate how sounds from each ear are fused into a coherent representation in the brain. Their research is described in Nature Communications.
Hearing scientist Daniel Polley, Ph.D., an investigator at Massachusetts ...
UCLA chemical engineering researchers have created a new synthetic metabolic pathway for breaking down glucose that could lead to a 50 percent increase in the production of biofuels.
The new pathway is intended to replace the natural metabolic pathway known as glycolysis, a series of chemical reactions that nearly all organisms use to convert sugars into the molecular precursors that cells need. Glycolysis converts four of the six carbon atoms found in glucose into two-carbon molecules known acetyl-CoA, a precursor to biofuels like ethanol and butanol, as well as fatty ...
Membrane proteins are responsible for transporting chemicals and messages between a cell and its environment. But determining their structure has proved challenging for scientists. A study by UC Santa Barbara's Han Research Group demonstrates a new tool to resolve the structure of membrane-embedded and membrane-associating proteins using the water dynamics gradient they found across and above the lipid bilayer as a unique ruler.
More than 25 percent of all human proteins are membrane proteins, which perform other essential functions, such as sensing and signaling. They ...
LA JOLLA, CA—September 30, 2013¬–A team led by scientists at The Scripps Research Institute (TSRI) has created the first comprehensive roadmap of the protein interactions that enable cells in the pancreas to produce, store and secrete the hormone insulin. The finding makes possible a deeper scientific understanding of the insulin secretion process—and how it fails in insulin disorders such as type 2 diabetes.
"The development of this insulin interaction map is unprecedented, and we expect it to lead us to new therapeutic approaches for type 2 diabetes," said William E. ...
COLUMBIA, Mo. ¬— As the oldest of the baby boomers begin to reach retirement age, a large percentage of Americans are thinking more and more about how much money they must save to be able to retire comfortably. Also, more and more employers are changing retirement benefits from defined-benefit plans, which guarantee some level of retirement income, to defined-contribution plans, which require employees to invest on their own for retirement. All of these changes, plus the recent economic recession, have created a difficult financial environment for future retirees. Now, ...
MADISON — Scientists at the University of Wisconsin-Madison have made a discovery that, if replicated in humans, suggests a shortage of zinc may contribute to diseases like Alzheimer's and Parkinson's, which have been linked to defective proteins clumping together in the brain.
With proteins, shape is everything. The correct shape allows some proteins to ferry atoms or molecules about a cell, others to provide essential cellular scaffolding or identify invading bacteria for attack. When proteins lose their shape due to high temperature or chemical damage, they stop working ...
VIDEO:
NASA planetary scientist Conor Nixon explains his discovery of propylene on Titan, Saturn's largest moon. Scientists have known about the presence of atmospheric hydrocarbons on Titan since Voyager 1 flew...
Click here for more information.
NASA's Cassini spacecraft has detected propylene, a chemical used to make food-storage containers, car bumpers and other consumer products, on Saturn's moon Titan.
This is the first definitive detection of the plastic ingredient ...
WASHINGTON, DC, September 26, 2013 -- In response to past economic crises such as the Great Depression, Americans demanded government policy solutions to widespread unemployment and rising income insecurity. But a new study in the October issue of the American Sociological Review found that public support for government efforts to address social problems actually declined in the wake of the 2008 economic crisis.
"We found it surprising that as the Great Recession emerged, the American public moved quickly toward lower levels of support for government policy solutions ...
To address the global phenomenon of disparities in respiratory health, the American Thoracic Society and the European Respiratory Society have released an official policy statement in which each pledges its commitment to reducing health disparities between the lowest and highest socioeconomic groups by continuing or initiating work with leaders from governments, academia, and other organizations to promote scientific inquiry and training, disseminate medical information and best practices, and monitor and advocate for public respiratory health.
The statement appears in ...
Philadelphia, PA, October 1, 2013 -- Resveratrol, a naturally occurring polyphenol compound produced by the skin of red grapes and peanuts, and found in red wine, has been touted as a beneficial supplement due to its anti-inflammatory and antioxidant properties. This has been supported by some experimental studies, whereas others suggest a lack of benefit. A new study using two multiple sclerosis (MS) models published in The American Journal of Pathology has found that resveratrol actually worsened MS-like neuropathology and inflammation and had no neuroprotective effects. ...
